Encompass Health Stock Forecast, Price & News

Encompass Health (NYSE:EHC) Frequently Asked Questions

Is Encompass Health a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Encompass Health stock.
View analyst ratings for Encompass Health or view top-rated stocks.

How has Encompass Health's stock been impacted by Coronavirus?

Encompass Health's stock was trading at $63.85 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EHC shares have decreased by 2.0% and is now trading at $62.57.
View which stocks have been most impacted by COVID-19.

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Tuesday, January 25th 2022.
View our earnings forecast for Encompass Health.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) released its quarterly earnings data on Wednesday, October, 27th. The company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.06 by $0.03. The business had revenue of $1.28 billion for the quarter, compared to analysts' expectations of $1.31 billion. Encompass Health had a trailing twelve-month return on equity of 19.87% and a net margin of 8.10%. The firm's revenue was up 9.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.78 EPS.
View Encompass Health's earnings history.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Thursday, October 21st. Investors of record on Monday, January 3rd will be paid a dividend of $0.28 per share on Tuesday, January 18th. This represents a $1.12 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date of this dividend is Friday, December 31st.
View Encompass Health's dividend history.

Is Encompass Health a good dividend stock?

Encompass Health pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.84%. The dividend payout ratio of Encompass Health is 27.59%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 24.72% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.
View Encompass Health's dividend history.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health updated its FY 2021 earnings guidance on Wednesday, November, 3rd. The company provided EPS guidance of $4.230-$4.380 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.450. The company issued revenue guidance of $5.08 billion-$5.13 billion, compared to the consensus revenue estimate of $5.18 billion.

What price target have analysts set for EHC?

9 Wall Street analysts have issued 1 year price objectives for Encompass Health's shares. Their forecasts range from $75.00 to $104.00. On average, they expect Encompass Health's share price to reach $90.67 in the next year. This suggests a possible upside of 44.9% from the stock's current price.
View analysts' price targets for Encompass Health or view top-rated stocks among Wall Street analysts.

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:

• Mark J. Tarr, President, Chief Executive Officer & Director
• Douglas E. Coltharp, Chief Financial Officer & Executive Vice President
• Elissa Joy Charbonneau, Chief Medical Officer
• John Patrick Darby, Secretary, Executive VP & General Counsel
• Andrew L. Price, Chief Accounting Officer & Senior Vice President

What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health CEO Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among Encompass Health's employees.

Who are some of Encompass Health's key competitors?

Some companies that are related to Encompass Health include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Tenet Healthcare (THC), Acadia Healthcare (ACHC), Petco Health and Wellness (WOOF), The Ensign Group (ENSG), Select Medical (SEM), Community Health Systems (CYH), U.S. Physical Therapy (USPH), Brookdale Senior Living (BKD), National HealthCare (NHC), Five Star Senior Living (FVE) and Capital Senior Living (CSU).
View all of EHC's competitors.

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include salesforce.com (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Who are Encompass Health's major shareholders?

Encompass Health's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (10.55%), Wellington Management Group LLP (8.22%), William Blair Investment Management LLC (3.11%), Victory Capital Management Inc. (1.70%), Bank of New York Mellon Corp (1.50%) and TimesSquare Capital Management LLC (1.42%). Company insiders that own Encompass Health stock include Andrew L Price, Andrew L Price, Donald L Correll, Donald L Correll, Elissa Joy Charbonneau, Elissa Joy Charbonneau, Mark J Tarr, Mark J Tarr, Terrance Williams and Terrance Williams.
View institutional ownership trends for Encompass Health.

Which major investors are selling Encompass Health stock?

EHC stock was sold by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., American Century Companies Inc., William Blair Investment Management LLC, Millennium Management LLC, Neuberger Berman Group LLC, BlackRock Inc., Bank of Nova Scotia, and Schroder Investment Management Group.
View insider buying and selling activity for Encompass Health or view top insider-selling stocks.

Which major investors are buying Encompass Health stock?

EHC stock was acquired by a variety of institutional investors in the last quarter, including Canyon Capital Advisors LLC, DekaBank Deutsche Girozentrale, Wellington Management Group LLP, Glenview Capital Management LLC, Polar Asset Management Partners Inc., Massachusetts Financial Services Co. MA, Deutsche Bank AG, and Apollo Management Holdings L.P..
View insider buying and selling activity for Encompass Health or or view top insider-buying stocks.

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $62.57.

How much money does Encompass Health make?

Encompass Health has a market capitalization of $6.23 billion and generates $4.64 billion in revenue each year. The company earns $284.20 million in net income (profit) each year or $4.06 on an earnings per share basis.

How many employees does Encompass Health have?

Encompass Health employs 43,000 workers across the globe.

When was Encompass Health founded?

Encompass Health was founded in 1984.

What is Encompass Health's official website?

The official website for Encompass Health is www.healthsouth.com.

Where are Encompass Health's headquarters?

Encompass Health is headquartered at 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at (205) 967-7116, via email at [email protected], or via fax at 205-969-4719.